The Silicon Review Recognizes NATROX® Wound Care as a Top 5 MedTech Company to Watch in 2025

We are thrilled to announce that NATROX® Wound Care has been named one of the “5 Best MedTech Companies to Watch in 2025” by The Silicon Review. This recognition underscores our commitment to transforming chronic wound care through innovative solutions like our NATROX® O₂ Continuous Topical Oxygen Therapy (cTOT). Our patient-centered approach aims to enhance healing outcomes, reduce complications, and improve the quality of life for individuals with chronic and non-healing wounds. View Article

At the heart of our mission our cTOT device, NATROX® O₂, a discreet, wearable therapy that delivers a consistent, low flow of highly concentrated oxygen directly to chronic wounds. This non-invasive, portable solution allows patients to receive effective therapy around the clock, seamlessly integrating into their daily lives. With regulatory approvals in over 25 countries, we continue to expand access to our groundbreaking products, ensuring that more patients worldwide can benefit from our innovative wound care solutions. View List

We extend our heartfelt gratitude to our dedicated team, healthcare partners, and patients who have supported us on this journey. This recognition inspires us to continue pushing the boundaries of wound care innovation and to remain steadfast in our mission to improve patient outcomes globally.